Results 101 to 110 of about 5,403 (175)

Tumor Microenvironment Reprogramming via Copper-Enriched Black Phosphorus Nanoplatform for Cuproptosis-Sensitized Low-Dose Radioimmunotherapy. [PDF]

Int J Nanomedicine
Chen Y, Wang J, Zheng D, Zhang W.
europepmc   +1 more source

Haploidentical Allogeneic Cell Transplantation in Relapsed/Refractory Multiple Myeloma. [PDF]

Cancer Manag Res
Frimmel J, Morgner A, Brogsitter C, Trautmann-Grill K, Kunadt D, Teipel R, Röllig C, Hänel M, Schetelig J, Stölzel F, Bornhäuser M.   +10 more
europepmc   +1 more source

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

JAMA Oncol
Shadman M, LeBlanc M, Rimsza L, Leonard JP, Smith SM, Li H, Friedberg JW.   +6 more
europepmc   +1 more source

An organolutetium nanosensitizer synergizes with PARP inhibition to unleash STING-mediated immunity for low-dose radioimmunotherapy. [PDF]

Theranostics
Zeng B, Ling K, Yuan Q, Chen Z, Zhang G, Kang W, Zheng X, Liao C, Mai Y, Huang Z, Huang R, Zhai T, Jiang H.   +12 more
europepmc   +1 more source

Establishment of ⁶⁸Ga-DOTA-Based Pretargeted Radioimmunodiagnosis. [PDF]

Mol Pharm
Veach DR, Burnes Vargas D, Islam B, Lee SG, Gajecki L, Vaughn BA, Yang G, Kalidindi TM, Pillarsetty NVK, Salehi N, Jaswal AP, Saha S, Le Roux AB, Xu H, Guo HF, Ouerfelli O, Cheung NV, Krebs S, Larson SM, Cheal SM.   +19 more
europepmc   +1 more source

Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer. [PDF]

Nat Cancer
Huang J, Theelen WSME, Belcaid Z, Najjar M, van der Geest D, Singh D, Cherry C, Balan A, White JR, Wehr J, Karchin R, Niknafs N, van den Heuvel MM, Velculescu VE, Smith KN, Baas P, Anagnostou V.   +16 more
europepmc   +1 more source

Correction to "In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy". [PDF]

ACS Omega
Allen KJH, Frank C, Jiao R, Malo ME, Bello M, De Nardo L, Meléndez-Alafort L, Dadachova E.   +7 more
europepmc   +1 more source

Editorial: Overcoming resistance in DDR inhibition: new targets and therapeutic strategies. [PDF]

Front Mol Biosci
Tsai CL, Gonçalves AC, Ahmed Z.
europepmc   +1 more source

Facts and Hopes in Radioimmunotherapy for Localized Stages of Cancer. [PDF]

Clin Cancer Res
Bosi C, Ho AY, Gregucci F, Formenti SC.
europepmc   +1 more source